Table 2 Cost (€) per alternative (screening boys and girls combined vs girls only) and incremental cost relative to screening in four non-screening scenarios with a 95% Credibility Interval (CrI)
| Â | Screening boys and girls | Screening girls only | ||||
|---|---|---|---|---|---|---|
| Â | Cost per child | Incremental cost per child | Probability incremental cost >0 | Cost per child | Incremental cost per child | Probability incremental cost >0 |
Screening | 57.0 (49 to 66) | - | Â | 50.6 (44 to 58) | - | Â |
Non-screening Norway | 57.1 (44 to 73) | 0.1 (−14 to 16) | 50% | 57.1 (44 to 73) | 6.5 (6 to 21) | 84% |
Non-screening 90% treatment rate of Lee et al. | 70.3 (59 to 84) | 13.3 (1 to 27) | 99% | 70.3 (59 to 85) | 18.4 (8 to 30) | >99% |
Non-screening 80% treatment rate of Lee et al. | 62.5 (52 to 75) | 5.5 (−6 to 18) | 82% | 62.5 (52 to 75) | 11.3 (2 to 22) | 99% |
Non-screening 70% treatment rate of Lee et al. | 54.7 (46 to 66) | −2.3 (−13 to 9) | 33% | 54.7 (46 to 66) | 4.3 (−4 to 14) | 82% |